Patients with rosacea experienced improvement with Emrosi, an oral minocycline hydrochloride extended-release product, ...
Zacks Investment Research on MSN5h
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer IndicationAstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback